{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:23:35Z","timestamp":1790414615527,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003712","name":"Korea Food Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003712","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"NRF","doi-asserted-by":"publisher","award":["2014R1A2A1A11052685"],"award-info":[{"award-number":["2014R1A2A1A11052685"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.canlet.2017.06.015","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T04:18:39Z","timestamp":1497932319000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells"],"prefix":"10.1016","volume":"403","author":[{"given":"Yong-Kyu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ui-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Taek","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Cheon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jong","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.06.015_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA Loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2017.06.015_bib2","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1182\/blood-2008-07-170282","article-title":"The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells","volume":"114","author":"Oehler","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.06.015_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/onc.2010.409","article-title":"BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients","volume":"30","author":"De Carvalho","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.06.015_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/sj.bjc.6604494","article-title":"PRAME expression and clinical outcome of breast cancer","volume":"99","author":"Epping","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.06.015_bib5","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.0501564102","article-title":"The gene expression signatures of melanoma progression","volume":"102","author":"Haqq","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2017.06.015_bib6","doi-asserted-by":"crossref","first-page":"17777","DOI":"10.1073\/pnas.0702518104","article-title":"A\u00a0functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors","volume":"104","author":"Epping","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2017.06.015_bib7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.leukres.2011.04.005","article-title":"Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells","volume":"35","author":"Tanaka","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.canlet.2017.06.015_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.bbrc.2012.02.110","article-title":"Expression and prognostic relevance of PRAME in primary osteosarcoma","volume":"419","author":"Tan","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.06.015_bib9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00277-008-0514-8","article-title":"Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia","volume":"87","author":"Ortmann","year":"2008","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.canlet.2017.06.015_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2011.08585.x","article-title":"Hypomethylation of PRAME promoter is associated with poor prognosis in myelodysplastic syndrome","volume":"154","author":"Qian","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.06.015_bib11","doi-asserted-by":"crossref","first-page":"45352","DOI":"10.18632\/oncotarget.9977","article-title":"PRAME expression and promoter hypomethylation in epithelial ovarian cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.06.015_bib12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.leukres.2012.02.030","article-title":"Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: effect of 5-AZA treatment","volume":"36","author":"Gutierrez-Cos\u00edo","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.canlet.2017.06.015_bib13","doi-asserted-by":"crossref","first-page":"e32165","DOI":"10.1371\/journal.pone.0032165","article-title":"NYESO-1\/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine","volume":"7","author":"Pollack","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2017.06.015_bib14","first-page":"159","article-title":"Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1","volume":"211","author":"Hromas","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.canlet.2017.06.015_bib15","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/jcb.25203","article-title":"Role and regulation of myeloid zinc finger protein 1 in cancer","volume":"116","author":"Eguchi","year":"2015","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.canlet.2017.06.015_bib16","doi-asserted-by":"crossref","first-page":"14183","DOI":"10.1016\/S0021-9258(18)98664-3","article-title":"A\u00a0retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells","volume":"266","author":"Hromas","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.06.015_bib17","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1128\/MCB.15.11.6075","article-title":"Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity","volume":"15","author":"Perrotti","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2017.06.015_bib18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1101\/gad.902301","article-title":"Mzf1 controls cell proliferation and tumorigenesis","volume":"15","author":"Gaboli","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2017.06.015_bib19","first-page":"9","article-title":"Suppression of tumorigenicity of human hepatocellular carcinoma cells by antisense oligonucleotide MZF-1","volume":"50","author":"Hsieh","year":"2007","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.canlet.2017.06.015_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1158\/1541-7786.MCR-09-0326","article-title":"Myeloid zinc finger 1 induces migration, invasion, and in\u00a0vivo metastasis through Axl gene expression in solid cancer","volume":"8","author":"Mudduluru","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2017.06.015_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.molcel.2012.01.029","article-title":"ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression","volume":"45","author":"Rafn","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2017.06.015_bib22","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/onc.2014.118","article-title":"The MZF1\/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss","volume":"34","author":"Tsai","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.06.015_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cellsig.2014.11.002","article-title":"Disordered signaling governing ferroportin transcription favors breast cancer growth","volume":"27","author":"Chen","year":"2015","journal-title":"Cell Signal"},{"key":"10.1016\/j.canlet.2017.06.015_bib24","doi-asserted-by":"crossref","first-page":"84785","DOI":"10.18632\/oncotarget.12626","article-title":"DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer","volume":"7","author":"Jia","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.06.015_bib25","doi-asserted-by":"crossref","first-page":"17588","DOI":"10.1074\/jbc.M512616200","article-title":"Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor","volume":"281","author":"Cho","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.06.015_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-62703-011-3_9","article-title":"Methylated DNA immunoprecipitation (MeDIP) from low amounts of cells","volume":"925","author":"Borgel","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2017.06.015_bib27","first-page":"913","article-title":"A\u00a0human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice","volume":"72","author":"Kozlowski","year":"1984","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2017.06.015_bib28","first-page":"2029","article-title":"Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis","volume":"51","author":"Zhang","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.06.015_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-1119(00)00281-X","article-title":"Human myeloid zinc finger gene MZF produces multiple transcripts and encodes a SCAN box protein","volume":"254","author":"Peterson","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2017.06.015_bib30","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.12659\/MSM.895642","article-title":"Identification of preferentially expressed antigen of melanoma as a potential tumor suppressor in lung adenocarcinoma","volume":"22","author":"Huang","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.canlet.2017.06.015_bib31","first-page":"1057","article-title":"PRAME promotes in\u00a0vitro leukemia cells death by regulating S100A4\/p53 signaling","volume":"20","author":"Xu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2017.06.015_bib32","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1038\/onc.2014.310","article-title":"Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress","volume":"34","author":"Chen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.06.015_bib33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3892\/ijo.2016.3793","article-title":"Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells","volume":"50","author":"Lee","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2017.06.015_bib34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/gcc.20465","article-title":"Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies","volume":"46","author":"Schenk","year":"2007","journal-title":"Gene. Chromosom. Cancer"},{"key":"10.1016\/j.canlet.2017.06.015_bib35","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1167\/iovs.14-13933","article-title":"The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma","volume":"55","author":"Rajaii","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.canlet.2017.06.015_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbrc.2014.07.082","article-title":"The glyceraldehyde 3-phosphate dehydrogenase gene (GAPDH) is regulated by myeloid zinc finger 1 (MZF-1) and is induced by calcitriol","volume":"451","author":"Piszczatowski","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517303968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517303968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T21:36:22Z","timestamp":1659130582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517303968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":36,"alternative-id":["S0304383517303968"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.06.015","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}